Study Shows Abbott's Tacrolimus Assay Demonstrates Consistent Organ Transplant ... Bradenton Herald 13, 2012 /PRNewswire/ -- A new study published in the journal Clinical Chemistry reported Abbott's (NYSE: ABT) ARCHITECT® Tacrolimus assay provides accurate and consistent medication monitoring for patients taking tacrolimus, an immunosuppressive ... |
